The strong correlation among PARP1 overactivation, limiting NAD+ pools and inhibition of SIRT1 activity is observed in a broad spectrum of human diseases, including xeroderma pigmentosum group A, progeroid diseases, ataxia telangiectasia and Cockayne syndrome. This evidence concerns the gene PARP1 and Cockayne syndrome.